XML 23 R18.htm IDEA: XBRL DOCUMENT
v3.19.3

Note 11 - Income Taxes | 12 Months Ended
--- | ---
Jun. 30, 2019
Notes to Financial Statements |
Income Tax Disclosure [Text Block] | Note 11. Income Taxes: Income before income taxes was comprised of the following (in thousands):
|  | Year Ended June 30, |
|  | 201 9 |  |  | 201 8 |  |  | 201 7 |
Domestic |  | $ | 64,081 |  |  | $ | 81,557 |  |  | $ | 81,721 |
Foreign |  |  | 47,934 |  |  |  | 44,395 |  |  |  | 30,240 |
Income before income taxes |  | $ | 112,015 |  |  | $ | 125,952 |  |  | $ | 111,961 |
The provision for income taxes consisted of the following (in thousands):
|  | Year Ended June 30, |
|  | 201 9 |  |  | 201 8 |  |  | 201 7 |
Taxes on income consist of: |  |  |  |  |  |  |  |  |  |  |  |
Currently tax provision: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  | $ | 16,090 |  |  | $ | 28,416 |  |  | $ | 28,462 |
State |  |  | 544 |  |  |  | 5,315 |  |  |  | 4,051 |
Foreign |  |  | 13,329 |  |  |  | 11,983 |  |  |  | 8,212 |
Total current tax provision |  |  | 29,963 |  |  |  | 45,714 |  |  |  | 40,725 |
Deferred tax provision: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  |  | (6,903 | ) |  |  | (40,378 | ) |  |  | (901 | )
State |  |  | (3,977 | ) |  |  | (1,381 | ) |  |  | (968 | )
Foreign |  |  | (3,142 | ) |  |  | (4,154 | ) |  |  | (2,981 | )
Total deferred tax provision |  |  | (14,021 | ) |  |  | (45,912 | ) |  |  | (4,850 | )
Total income tax provision |  | $ | 15,942 |  |  | $ | (198 | ) |  | $ | 35,875 |
The Company’s effective income tax rate for fiscal 2019 was 14.2% vs ( 0.2% ) in the prior year. The change in the effective tax rate for fiscal 2019 and 2018 was driven by changes in net discrete tax benefits of $12.7 million and $34.4 million for fiscal year 2019 and 2018, respectively. The Company's discrete tax benefits in fiscal 2019 primarily related to share-based compensation excess tax benefits of $7.2 million, $3.2 million related to current year acquisitions, and $2.0 million for tax refunds relating to certain state apportionments. The current year was benefited from acquisition payments made to employees and third parties, which were deductible for tax purposes. In fiscal 2018, the Company recognized net discrete tax benefits of $34.4 million. The primary driver in fiscal 2018 discrete tax benefits was a discrete net tax benefit of $33.0 million related to the Tax Act (as described further below). This net tax benefit consisted of $36.5 million due to the re-measurement of the Company’s deferred tax accounts to reflect the U.S. federal corporate tax rate reduction impact to our net deferred tax balances offset by expense for the federal transition tax of $3.3 million. Also impacting the Company’s fiscal 2018 effective tax rate was a $2.2 million tax benefit related to stock option exercises offset by a net discrete tax expense of $4.2 million related to the revaluation of contingent consideration, which is not a tax deductible expens e. On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was enacted, which reduced the U.S. federal corporate tax rate from 35% to 21%, required companies to pay a one -time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred and created new taxes on certain foreign sourced earnings. The Tax Act added many new provisions including changes the deduction for executive compensation, a tax on global intangible low taxed income (“GILTI”), the base erosion anti abuse tax (“BEAT”) and a deduction for foreign derived intangible income (“FDII”). The SEC staff issued Staff Accounting Bulletin (“SAB 118” ) later codified as ASU 2018 - 05 Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 118, which provides a measurement period of up to one year from the Tax Act’s enactment date to complete the accounting for the effects of the Tax Act. The end of the measurement period allowed under ASU 2018 - 05 was December 31, 2018. However, the Company anticipates additional interpretations and clarifications to be issued by the U.S. Treasury Department, which may affect future period tax calculations. The Company made the accounting policy election to treat taxes due on U.S. inclusions in taxable income related to GILTI as a current period expense when incurred. The following is a reconciliation of the federal tax calculated at the statutory rate of to the actual income taxes provided (in thousands):
|  | Year Ended June 30, |
|  | 201 9 |  |  | 201 8 |  |  | 201 7 |
Income tax expense at federal statutory rate |  |  | 21.0 | % |  |  | 28.1 | % |  |  | 35.0 | %
State income taxes, net of federal benefit |  |  | 0.8 | % |  |  | 2.5 | % |  |  | 1.9 | %
Qualified production activity deduction |  |  | - | % |  |  | (2.4 | )% |  |  | (3.4 | )%
Research and development tax credit |  |  | (1.6 | )% |  |  | (1.4 | )% |  |  | (1.4 | )%
Contingent consideration adjustment |  |  | (0.4 | )% |  |  | 3.3 | % |  |  | 4.1 | %
Foreign tax rate differences |  |  | 0.2 | % |  |  | (3.5 | )% |  |  | (4.6 | )%
Option exercises |  |  | (5.8 | )% |  |  | (1.8 | )% |  |  | - | %
Domestic tax legislation changes |  |  | 1.7 | % |  |  | (26.2 | )% |  |  | - | %
State apportionment changes |  |  | (2.3 | )% |  |  | - |  |  |  | - |
Other, net |  |  | 0.6 | % |  |  | 1.2 | % |  |  | 0.4 | %
Effective tax rate |  |  | 14.2 | % |  |  | (0.2 | )% |  |  | 32.0 | %
Deferred taxes on the Consolidated Balance Sheets consisted of the following temporary differences (in thousands):
|  | June 30 |
|  | 201 9 |  |  | 201 8 |
Inventory |  | $ | 7,743 |  |  | $ | 5,873 |
Net operating loss carryovers |  |  | 33,294 |  |  |  | 15,938 |
Tax credit carryovers |  |  | 9,640 |  |  |  | 7,029 |
Excess tax basis in equity investments |  |  | 3,433 |  |  |  | 2,813 |
Deferred compensation |  |  | 10,333 |  |  |  | 7,806 |
Derivative - cash flow hedge |  |  | 2,921 |  |  |  | - |
Other |  |  | 5,207 |  |  |  | 3,864 |
Valuation allowance |  |  | (6,974 | ) |  |  | (2,978 | )
Deferred tax assets |  |  | 65,597 |  |  |  | 40,345 |
Net unrealized gain on available-for-sale investments |  |  | (4,542 | ) |  |  | (8,384 | )
Intangible asset amortization |  |  | (141,998 | ) |  |  | (111,247 | )
Depreciation |  |  | (8,371 | ) |  |  | (6,349 | )
Other |  |  | (440 | ) |  |  | (658 | )
Deferred tax liabilities |  |  | (155,351 | ) |  |  | (126,638 | )
Net deferred tax liabilities |  | $ | (89,754 | ) |  | $ | (86,293 | )
A deferred tax valuation allowance is required when it is more likely than not that all or a portion of deferred tax assets will not be realized. The valuation allowance as of June 30, 2019 was $7.0 million, an increase of $4.0 million from the prior year. The change was driven by an increase in the valuation allowance for the Company’s net operating loss and credit carryforwards for fiscal 2019 acquisitions. As of June 30, 2019, the $7.0 million valuation allowance relates to certain foreign and state tax net operating loss and state credit carryforwards that existed at the date the Company acquired Quad, Exosome, ACD, Novus, ProteinSimple and CyVek as well as immaterial amounts generated after the acquisitions. The Company believes it is more likely than not that these tax carryovers will not be realized. As of June 30, 2019, the Company has federal operating loss carryforwards of approximately $98.2 million and state operating loss carryforwards of $137.4 million from its acquisitions of Quad, Exosome, ACD, ProteinSimple and CyVek, which are not limited under IRC Section 382. As of June 30, 2019, the Company has foreign net operating loss carryforwards of $13.6 million. The net operating loss carryforwards expire between fiscal 2020 and 2035. The Company has a deferred tax asset of $28.2 million , net of the valuation allowance discussed above, related to the net operating loss carryovers. As of June 30, 2019, the Company has federal and state tax credit carryforwards of $5.2 million and $4.4 million, respectively. The federal tax credit carryforwards expire between 2028 and 2038. The majority of the state credit carryforwards have no expiry date. The Company has a deferred tax asset of $7.7 million, net of the valuation allowance discussed above, related to the tax credit carryovers. The Company has not recognized a deferred tax liability for unremitted foreign earnings of approximately $160 million from its foreign operations because its subsidiaries have invested or will invest the undistributed earnings indefinitely. The transition tax included as part of the Tax Act resulted in the previously untaxed foreign earnings being included in the federal and state fiscal 2018 taxable income. The one -time transition tax was based on certain foreign earnings for which earnings have been previously indefinitely reinvested as well as the amount of earnings held in cash and other specified assets. No additional income taxes have been provided for cumulative unremitted foreign earnings as at this time our intention with respect to unremitted foreign earnings is to continue to indefinitely reinvest outside the U.S. those earnings needed for working capital or additional foreign investment. If there are policy changes, we would record applicable taxes at that time. We continue to analyze our global working capital requirements and the potential tax liabilities that would be incurred if the non-U.S. subsidiaries distribute cash to the U.S. parent, which include local country withholding tax and potential U.S. state taxation. In addition, we anticipate that further guidance from the IRS and US Treasury related to the Tax Act could impact the amount of any related taxes. Therefore, it is not practical to estimate the amount of the deferred income tax liabilities related to investments in these foreign subsidiaries. The following is a reconciliation of the beginning and ending balance of unrecognized tax benefits (in thousands):
|  | Year Ended June 30, |
|  | 201 9 |  |  | 201 8 |  |  | 201 7 |
Beginning balance |  | $ | 1,947 |  |  | $ | 1,747 |  |  | $ | 1,480 |
Additions due to acquisitions |  |  | 900 |  |  |  |  |  |  |  | 628 |
Additions for tax positions of current year |  |  | 2,185 |  |  |  | 35 |  |  |  | 13 |
Closure of tax years |  |  |  |  |  |  |  |  |  |  | (374 | )
Tax reform |  |  |  |  |  |  | 165 |  |  |  |  |
Ending balances |  | $ | 5,032 |  |  | $ | 1,947 |  |  | $ | 1,747 |
The Company does not believe it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase in the next twelve months. The Company files income tax returns in the U.S federal and certain state tax jurisdictions, and several jurisdictions outside the U.S. The Company's federal returns are subject to tax assessment for 2016 and subsequent years. State and foreign income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -URI http://asc.fasb.org/topic&trid=2144680 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration